All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Talking to your patients with Waldenstrom Macroglobulinemia
Bookmark this article
Waldenstrom’s Macroglobulinemia (WM) is a rare hematological malignancy and many healthcare professionals (HCPs) may only treat a handful of patients with the condition throughout their careers. There is a lack of education about the disease and its treatment in patients with WM. Therefore, HCPs treating patients with WM face challenges in communicating key information about the disease and treatment options to patients.
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) developed a reference guide to assist communication between HCPs and patients with WM to address this unmet need. As part of our ongoing partnership with the IWMF, the Lymphoma Hub is happy to present a concise quick reference guide to assist time-pressed HCPs treating patients with WM.
For more from the IWMF click here.
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Thank youNewsletter
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox